STEVE GILLIS

Profile

First Name

: STEVE

Middle Name

:

Last Name

: GILLIS

Related Companies
Titles
Company Name
Related People
DIRECTOR
XORI CORP
FRED ESHELMAN, THONG LE, STUART J. MACKEY, NANCY MAIZELS, LINDSAY RAYLE, DAVID SCHUBERT, CHAD WAITE, CARL WEISSMAN
DIRECTOR
ONCOFACTOR CORP
LEE BABISS, THONG LE, DAVID MCELLIGOTT, JANIS NAEVE, LINDSAY RAYLE, DAVID SCHUBERT, CHAD WAITE, CARL WEISSMAN
DIRECTOR
VARIATION BIOTECHNOLOGIES (US), INC.
DAVID E. ANDERSON, JEFF BAXTER, ADAM BUCKLEY, KEVIN FORREST, STEPHEN GILLIS, STEVEN GILLIS, MARC J. KIRCHMEIER, JEFFREY LEIDEN, EGIDIO NASCIMENTO, SCOTT ROCKLAGE, MICHAEL STEINMETZ, STEVE VIGNAU, STEVEN VIGNAU
DIRECTOR
LYCERA CORP
KRISTINA BUROW, KRISTINA BURROW, DAVID CANTER, STEVEN GILLIS, GARY GLICK, GARY D. GLICK, MICHAEL HAYDEN, ROBERT KAMEN, NINA KJELLSON, JEFFREY LEIDEN, TIM MAYLEBEN, TIMOTHY MAYLEBEN, KATHLEEN M. METTERS, PAUL SEKHRI, MICHAEL STEINMETZ
DIRECTOR
VBI VACCINES INC.
DAVID ANDERSON, JEFF BAXTER, ADAM T. BUCKLEY, T. ADAM BUCKLEY, SAM CHAWLA, TRENT DAVIS, MICHEL DE WILDE, MICHEL DEWILDE, MARC KIRCHMEIER, EGIDIO NASCIMENTO, CHARLES L.F. PAULSON, CHESTER L.F. PAULSON, SHANNON P. PRATT, D.B.A., PAUL F. SHOEN, MURRAY G. SMITH, MICHAEL STEINMETZ, ALAN TIMMINS, ALAN P. TIMMINS
DIRECTOR
ONCORESPONSE INC
ALICE BEXON, ROBERTO DE PONTI, ROBERTO DEPONTI, CAROL GALLAGHER, STEVEN GILLIS, ALAN GINSBERG, RUSS HAWKINSON, PATRICK JOSEPH HOJLO, WENDE HUTTON, NATHAN JORGENSEN, TED KOUTOUZIS, BOB LECHLEIDER, ROBERT J. LECHLEIDER, SEAN MCCARTHY, SEAN A. MCCARTHY, JOHN MCKEARN, ANDREW PERLMAN, KAMAL PURI, KAMAL D. PURI, CHRIS RUSSELL, CHRISTOPHER A. RUSSELL, CLIFFORD STOCKS, CLIFFORD J. STOCKS, KRISTINE SWIDEREK, GEETA VEMURI, DAGUANG WANG
DIRECTOR
LODO THERAPEUTICS CORP
BARBARA DALTON, M. JOHNSTON ERWIN, THONG LE, JOEL MARCUS, DAVID MCELLIGOTT, DAVID POMPLIANO, LINDSAY RAYLE, DAVID SCHUBERT, JAMES SULLIVAN, MISTI USHIO, ASISH XAVIER
DIRECTOR
PETRA PHARMA CORP
BARBARA DALTON, M. JOHNSTON ERWIN, JENNA FOGER, THONG LE, JOEL MARCUS, DAVID MCELLIGOTT, BRIAN O-CALLAGHAN, LINDSAY RAYLE, DAVID RENAS, DAVID SCHUBERT, PAUL SEKHRI, JAMES SULLIVAN, MISTI USHIO, ASISH XAVIER, ALBERT YU
DIRECTOR
APOGEN BIOTECHNOLOGIES, INC.
JOHNSTON ERWIN, M. JOHNSTON ERWIN, KENO GUTIERREZ, IAN A.W. HOWES, THONG LE, JOEL MARCUS, DAVID MCELLIGOTT, LINDSAY RAYLE, JOHN SANTINI, DAVID SCHUBERT, JAMES SULLIVAN, ASISH XAVIER
DIRECTOR
RODEO THERAPEUTICS CORP
MARGARITA CHAVEZ, KATIE HEWITT, IAN HOWES, THONG LE, JOEL MARCUS, SANFORD MARKOWITZ, KENDALL MOHLER, LINDSAY RAYLE, SUZANNE RETTENMIER, DAVID SCHUBERT, JAMES SULLIVAN, ASISH XAVIER, TADATAKA YAMADA
DIRECTOR, EXECUTIVE OFFICER, PROMOTER
PRONIRAS CORP
M. JOHNSTON ERWIN, STEVEN GILLIS, THONG LE, JOEL MARCUS, LINDSAY RAYLE, ATUL SARAN, DAVID SCHUBERT, CHRISTOPHER TOOMBS, ASISH XAVIER
DIRECTOR
MAGNOLIA NEUROSCIENCES CORP
MICHAEL BARAN, MARGARITA CHAVEZ, BARBARA DALTON, M. JOHNSTON ERWIN, IAN HOWES, THONG LE, ALICE LY, JOEL MARCUS, KENDALL MOHLER, DAVID SCHUBERT, ASISH XAVIER
DIRECTOR
VBI VACCINES INC/BC
DAVID ANDERSON, DAVID E. ANDERSON, RON BARBARO, JEFF BAXTER, JEFFREY R. BAXTER, NELL BEATTIE, DAMIAN BRAGA, ANNIE CHAN, SAM CHAWLA, VIC CHEVILLON, VICTOR CHEVILLON, DOROTHY CHIN, JOANNE CORDEIRO, MICHEL DE WILDE, FRANCISCO DIAZ-MITOMA, CARLOS H. FERNANDEZ-MAZZI, STEVEN GILLIS, WILLIAM C. GLASIER, TOMER KARIV, ATHENA KARTSAKLIS, CURT LOCKSHIN, ADAM LOGAL, JAMES MARTIN, AVI MAZALTOV, AVI E. MAZALTOV, BLAINE MCKEE, CHRISTOPHER MCNULTY, EGIDIO NASCIMENTO, SCOTT REQUADT, ROBERT ROBERTS, GARY ROBERTSON, STEVEN RUBIN, LISA SHARP, RON TREMBLAY, DAVID WOLFIN, LOUIS WOLFIN
DIRECTOR
ALLY THERAPEUTICS, INC.
DAVID CORDO, TINA LIU, BOB MORE, ERICA WHITTAKER
DIRECTOR
SKYLARK BIO, INC.
JODI A. COOK, GIAMPIERO DE LUCA, WILL MCLEAN, NILAY THAKAR
DIRECTOR
BASKING BIOSCIENCES, INC.
AIDEN ACEVES, DAVID ADAIR, HANNAH CHANG, RYAN HELON, DAN MYERS, THOMAS NEEDHAM, SHAHID NIMJEE, ARI NOWACEK, JULIA OWENS, RICHARD SHEA, BRUCE SULLENGER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-10-22
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-10-31 
2024-04-19
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-08 
2023-11-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-10-31 
2023-08-14
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-08 
2022-08-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-08 
2021-11-23
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-07-07 
2020-07-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-07-07 
2020-05-27
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-05-22 
2020-05-01
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2020-04-24 
2020-04-02
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-26 
2020-03-31
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-08-30 
2019-10-21
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-08-30 
2019-08-09
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-31 
2019-08-01
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-08-30 
2019-07-11
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-08-22 
2019-04-26
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-08-30 
2019-03-29
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-26 
2018-12-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-26 
2018-12-07
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-12-04 
2018-09-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-08-30 
2018-08-24
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-11-23 
2018-08-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-08-03 
2018-01-22
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-23 
2017-09-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-08-22 
2017-08-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-07-18 
2017-03-23
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-09-30 
2017-01-04
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-21 
2017-01-04
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-23 
2016-12-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-11-23 
2016-05-26
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-09-30 
2016-01-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-23 
2016-01-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-21 
2015-10-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-09-30 
2015-08-26
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2015-08-13 
2014-08-08
D
Link
BIOTECHNOLOGY 
SECURITY BROKERS, DEALERS + FLOTATION COMPANIES [6211] 
DECLINE TO DISCLOSE 
Equity 
2014-07-25 
2014-08-08
D
Link
BIOTECHNOLOGY 
SECURITY BROKERS, DEALERS + FLOTATION COMPANIES [6211] 
DECLINE TO DISCLOSE 
Equity 
2014-07-25 
2014-04-04
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2014-03-21 
2013-10-21
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2013-10-11 
2013-09-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-08-22 
2012-06-28
D/A
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2009-04-07 
2012-02-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-12-14 
2011-05-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-05-05 
2009-05-15
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2009-05-01 
2009-05-15
D/A
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2009-05-01